What are the causes of meningiomas arising along the superior sagittal sinus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Meningiomas Along the Superior Sagittal Sinus

Meningiomas along the superior sagittal sinus arise from arachnoid cap cells in the meninges at this location, with the fundamental causes being genetic alterations (primarily NF2 gene loss on chromosome 22q), prior cranial radiation exposure, and inherited genetic syndromes, though most cases are idiopathic. 1

Primary Etiologic Mechanisms

Genetic/Molecular Basis

The initial cytogenetic event is loss of genetic material on the long arm of chromosome 22 (22q12), near the NF2 gene 1. This occurs in the arachnoid cells present along the superior sagittal sinus and represents the foundational molecular event. The location along the superior sagittal sinus is simply where these arachnoid cells reside anatomically—meningiomas can develop anywhere meninges exist 1.

Key molecular alterations include:

  • Loss of chromosome 22q (NF2 region) - the primary initiating event
  • Additional chromosomal losses (1p, 14q, 6p/q, 10q, 14q, 18p/q) accumulate with progression 1, 2
  • TRAF7 mutations (20-25% of meningiomas, but mutually exclusive with NF2 mutations) 3
  • AKT1, KLF4, SMO mutations in specific molecular subgroups 3, 2

Radiation-Induced Meningiomas

Prior cranial irradiation is a well-established cause, even from low-dose radiation such as dental radiographic examinations after intervals up to 35 years 4. Radiation-induced meningiomas:

  • Can occur in the second decade of life after high-dose childhood irradiation for leukemia, astrocytoma, medulloblastoma, retinoblastoma, or histiocytosis 1
  • Show complex structural and numerical chromosomal abnormalities consistent with radiation-induced DNA damage 1
  • Infrequently show NF2 gene abnormalities, distinguishing them from sporadic cases 1
  • Generally follow an indolent clinical course 1

Inherited Genetic Syndromes

20-40% of meningiomas develop in patients with Neurofibromatosis type 2 (NF-2), even when other NF-2 manifestations are not evident 1. Additional syndromes include:

  • Gorlin syndrome (multiple basal cell carcinoma syndrome) - especially in patients who received cranial radiotherapy 1
  • Rubinstein-Taybi syndrome 1
  • Rare familial meningiomas without underlying genetic syndrome 1

Hormonal Influences

The female preponderance (3:2 to 2:1 female:male ratio in adults) and expression of progesterone receptors on >50% of meningiomas suggest gestagen influence on proliferation 4. However, this represents a modifying factor rather than a primary cause, and notably, pediatric meningiomas show male predominance 1.

Location-Specific Considerations

The superior sagittal sinus location is not caused by unique factors—it simply reflects the anatomic distribution of arachnoid cells. The convexity of the hemispheres (including parasagittal regions along the superior sagittal sinus) is the most common location for meningiomas, with up to 90% being supratentorial 1.

Clinical caveat: Parasagittal meningiomas invading the superior sagittal sinus pose specific management challenges due to risk of venous infarction if functional sinus or bridging veins are compromised 5, 6, but this relates to treatment complications rather than causation.

Idiopathic Cases

Most meningiomas remain idiopathic 7, 4—no identifiable radiation exposure, genetic syndrome, or clear predisposing factor is found in the majority of cases. The spontaneous accumulation of NF2 and other genetic alterations in arachnoid cells represents the fundamental pathogenic mechanism in these sporadic cases.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.